These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2118 related articles for article (PubMed ID: 27617575)

  • 1. Wnt signaling in cancer.
    Zhan T; Rindtorff N; Boutros M
    Oncogene; 2017 Mar; 36(11):1461-1473. PubMed ID: 27617575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of noncanonical Wnt signaling in cancers.
    Chen Y; Chen Z; Tang Y; Xiao Q
    Biomed Pharmacother; 2021 Jan; 133():110946. PubMed ID: 33212376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
    Dzobo K; Thomford NE; Senthebane DA
    OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/beta-catenin pathway: modulating anticancer immune response.
    Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
    J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway.
    Xu W; Lin H; Zhang Y; Chen X; Hua B; Hou W; Qi X; Pei Y; Zhu X; Zhao Z; Yang L
    J Exp Clin Cancer Res; 2011 Oct; 30(1):103. PubMed ID: 22032476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.
    Song P; Gao Z; Bao Y; Chen L; Huang Y; Liu Y; Dong Q; Wei X
    J Hematol Oncol; 2024 Jun; 17(1):46. PubMed ID: 38886806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Wnt/β-catenin signaling pathway by bioactive food components.
    Tarapore RS; Siddiqui IA; Mukhtar H
    Carcinogenesis; 2012 Mar; 33(3):483-91. PubMed ID: 22198211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
    Fodde R; Brabletz T
    Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors.
    Samant C; Kale R; Pai KSR; Nandakumar K; Bhonde M
    Biochem Biophys Res Commun; 2024 Oct; 729():150348. PubMed ID: 38986260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt Signaling and Drug Resistance in Cancer.
    Zhong Z; Virshup DM
    Mol Pharmacol; 2020 Feb; 97(2):72-89. PubMed ID: 31787618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
    Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
    Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discovery approaches to target Wnt signaling in cancer stem cells.
    Curtin JC; Lorenzi MV
    Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
    Cui J; Jiang W; Wang S; Wang L; Xie K
    Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.
    Tabatabai R; Linhares Y; Bolos D; Mita M; Mita A
    Target Oncol; 2017 Oct; 12(5):623-641. PubMed ID: 28653295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wnt signaling pathway in cancer.
    Duchartre Y; Kim YM; Kahn M
    Crit Rev Oncol Hematol; 2016 Mar; 99():141-9. PubMed ID: 26775730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells.
    Duchartre Y; Kim YM; Kahn M
    Methods Mol Biol; 2017; 1613():463-478. PubMed ID: 28849572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Cristóbal I; Rincón R; Manso R; Rojo F; García-Foncillas J
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25136032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 106.